Eduardo Aparicio-Minguijón

7PUBLICATIONS
22CO-AUTHORS
Medical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 19, 2026
Epidemiology and Risk Factors for Infection in Multiple Myeloma Patients Treated With Bispecific Antibodies.

|Mar 11, 2026
Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial).

Rafael San-Juan, Julia Origüen, Mario Fernández-Ruiz

|Feb 20, 2026
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice.

Jorge Boán, Eduardo Aparicio-Minguijón, Mario Fernández-Ruiz

|Jan 16, 2026
Necrotizing gingival infection due to Trichoderma longibrachiatum in an hematopoietic stem cell transplant recipient: case report.

Eduardo Aparicio-Minguijón, Nieves López-Muñoz, Pilar Martínez-Sánchez

|Dec 24, 2025
The Unnoticed Threat: Clinical Characteristics, Risk Factors, and Outcome of Mucormycosis in Solid Organ Transplantation.

Jorge Boán, Mario Fernández-Ruiz, Eduardo Aparicio-Minguijón

|Dec 01, 2025
Skin and Soft Tissue Mucormycosis in Patients Receiving Bruton Tyrosine Kinase Inhibitors: Case Report and Literature Review.

Eduardo Aparicio-Minguijón, Nieves López-Muñoz, Jorge Boán

Pageof 2

Frequent Collaborators

6 joint publications

Mario Fernández-Ruiz

6 joint publications

Jorge Boán

5 joint publications

José María Aguado

4 joint publications

Francisco López-Medrano